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INTRODUCTION 
‘The diabetic foot may be defined as a group of syndromes in which neuropathy, 
ischaemia, and infection lead to tissue breakdown resulting in morbidity and possible 
amputation’ 
Diabetes is no longer a disease of the affluent west. Global prevalence of diabetes in 
2003 was estimated to be 194million.By 2030, this figure is predicted to rise to 366million 
due to longer life expectancy and changing dietary habits. In fact the prevalence is soaring in 
southern India it may reach an astronomical figure 13% to 18%.In such a scenario knowing 
about the disease is important1. Foot complications in diabetics are on the rise and this is 
attributable to many reasons. India with the oncoming diabetic epidemic and the increased 
geriatric population is bound to have a good percentage of its population with foot ulcers. 
Amputations and the ulcers that precede limb loss are largely preventable. Health education 
and organized foot care programmes are required to check this public health problem. 
Diabetes mellitus affects every system in the body and it can be well said ‘knowing diabetes, 
is like knowing entire medicine’.Every diabetic needs to know in detail about the changes in 
the foot. Changes are apparent and what the mind does not know the eyes do not see. Elderly 
diabetics with compromised vision due to retinopathy and arthritic stiff spine do not inspect 
their feet at all. The metabolic complications namely raised blood sugar, etc., are now easily 
controlled while the foot, kidney, eye and heart are targets of long term complications. Blood 
sugar values just tell you the state of diabetes but every cell in the blood relentlessly 
undergoes changes which are reflected in long term complications. Among all the long term 
complications foot involvement is the foremost complication. The other organs affected are 
heart, brain, eyes and the kidneys. Diabetic patients with foot ulcers constitute the majority of 
the hospital admissions. The number of admissions to hospitals for foot related complications 
is increased and the limbs amputated are more than those lost in both world wars. This is of 
great socioeconomic importance as majority of them are in the prime earning age group and 
are poor. The treatment of foot ulcers needs frequent surgical consultations, use of costly 
antibiotics, repeated investigations, dressings and minor surgical procedures. The patients 
with compromised mobility find commuting to the hospital difficult. Hospital admissions are 
expensive. These eventual foot loss are largely preventable and adequate foot care prevents 
foot loss. Treatment of diabetes transgresses specialty and hence the need of the hour is 
‘multidisciplinary approach’2. This is well exemplified in the management of foot 
complications. This requires the expertise of diabetic physician, vascular surgeon, 
orthopaedician, neurologist, and orthoptist and social workers. With voluminous literature 
available there is a need for a comprehensive study on all aspects diabetic foot disease. This 
study is useful for all health care professionals involved in the management of diabetic foot 
disease on revascularization. Our country has a large rural population of bare foot walkers. 
The importance of wearing footwear must be impressed to them. This will witness a 
reduction of foot ulcer and eventual amputations. Footwear industry can sponsor patient 
education programmes and wearing footwear inside the house also need to be encouraged. 
Various research papers published world over have shown that “reaching out the 
patient” approach has helped in reducing the amputation rate dramatically. This is more 
important than tertiary care. The economic impact of diabetic foot problems is very 
significant, as patients with foot ulcers need long, expensive hospital stay away from work. 
Loss of the limb is a disaster. “The most common cause of amputation of the lower limb is 
diabetes mellitus”.Early detection and attention to warning signals in the foot definitely can 
prevent amputations. The patient once a diabetic is always a diabetic because the genetic 
cause persists. Patients need to have a complete knowledge of the chronological changes that 
takes place in the leg and foot. The elderly diabetic with a bad spine and failing vision due to 
diabetic retinopathy is ‘divorced from the feet’, as they have all the difficulty of seeing the 
seeing the changes in the feet. The high risk group should be identified and intensive health 
education alone will avert amputation. 
 
 
 
 
 
 
 
 
 
 
VASCULAR SURGERY IN DIABETIC FOOT: 
Vascular surgery is one of the recent specialization and essentially, vascular surgery 
involves removal of blocks and by passing obstructions. Early vascular surgical procedures 
were directed in correcting blood vessel aneurysms. John hunter pioneered in ligation of 
popliteal aneurysms and Alexis carrel designed the method of joining the cut blood vessels. 
This fetched him a Noble Prize. Angiography was made possible due to the efforts of Moniz, 
Dos Santos and Seldinger. The problem of clotting of blood in crucial vessels was overcome 
with the invention of Heparin by McLean. With more need of blood vessel substitutes arose, 
grafts were designed. Michael Debackey of Texas contributed to the advances in the 
management of abdominal aortic aneurysms. Managing war victims and road transport 
accident victims necessitated rapid advances in vascular reconstruction. Short segment blocks 
are treated with endovascular procedures and long segment blocks are treated with by-pass 
grafts using synthetics or vein grafts. Acute blocks are dissolved using intra-arterial drugs and 
big clots are dissolved using intra-arterial drugs and big clots are removed using balloon 
catheters. When the blood supply is reduced to a level that threatens the very survival of the 
limb, the patient needs emergency management. Judicious and appropriate use of 
revascularization results in a cumulative limb salvage rate of greater than 70% at 5 years in 
high risk groups. Restoration of flow can be achieved either by management or by Bypass 
surgery or by a combination of both. There is no increased morbidity for reconstructive 
surgery in a diabetics and the long-term patency rates are comparable to the 
nondiabetics.Strandness et al, reported that diabetic patients had more infrapopliteal disease3. 
King et al found greater involvement of the profundafemoris in diabetic patients4. More 
patients will require distal bypasses , as diabetic macroangiopathy affects popliteal 
trifurcation and dorsalis pedis is patent in majority of patients.Diabetic patients seemed to do 
less well with these grafts in terms of patency and limb salvage although not statistically 
different. Even when the distal by-pass is done as it establishes sufficient vascularity to heal 
ischemic ulcers. Some authors opine that in patients with peripheral arterial disease, diabetic 
patients have worse arterial disease and a poorer outcome than non-diabetic patients.All 
ischemic ulcers with poor peripheral arterial flow of the foot must be evaluated and assessed 
for the feasibility of revascularization. It is important to realize that the majority of the 
patients with diabetes with peripheral arterial disease are candidates for distal bypass surgery 
to the pedal vessels.LoGerfo et al demonstrated that extreme distal bypass surgery to the 
pedal vessels in diabetics was inversely related to amputation rate5. With this same procedure 
Pomposelli et al demonstrated a 3year patency rate of 87% and a limb salvage rate of 92%. 
Various authors have confirmed the findings. 
Lower limb ischemia may cause nonhealing ulcers, infection, amputation and even 
mortality in diabetic patients. In this study, we review our data of ischemic lower limb 
revascularization procedures in diabetic patients and present results of its efficacy. 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIM OF THE STUDY       
                                                          
1) To study the percentage of lower limb ischemia in patients with diabetic foot. 
2) To study the Efficacy of the lower limb revascularization procedures( open and 
endovascular) 
               And conventional medical management in ischemic diabetic foot. 
3) To study the role of antiplatelet and anticoagulant agents in ischemic diabetic foot. 
4) To study the percentage of patients with diabetic foot prevented from Amputations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
HISTORICAL REVIEW 
 
The term DIABETES meaning “to pass through” was first coined by Aretacus in 2nd 
century AD.  
The sweet taste of diabetic urine was noted in 6th century AD by an Indian physician 
Susrutha who called it as “madhumeha”.  
The term “DIABETES MELLITUS” was coined by John Rollo in 18th century. 
Claude Bernard described the metabolism of diabetes in 19th century. 
Amputations as a form of therapy date back to Hippocrates (460-377 BC).  
Ambrose Pare (15-10-1590) is considered to be the originator of modern principles of 
amputations surgery.  
During the Napoleonic wars, Dominique Jean Larry (1776-1842) continued and 
expanded the principles of amputations.  
Angioplasty was first described by the US interventionalradiologist CharlesDotter in 
1964.Dr. Dotter pioneered modern medicine with the invention of angioplasty and the 
catheter-delivered stent, which were first used to treat peripheral arterial disease. On January 
16, 1964, Dotter percutaneously dilated a tight, localized stenosis of 
the superficialfemoralartery (SFA) in an 82-year-old woman with painful leg ischemia and 
gangrene who refused leg amputation. After successful dilation of the stenosis with a guide 
wire and coaxial Teflon catheters, the circulation returned to her leg. The dilated artery stayed 
open until her death from pneumonia two and a half years later. Charles Dotter is commonly 
known as the "Father of InterventionalRadiology" and was nominated for the NobelPrize in 
medicine in 19786. 
On 16 January 1964, Dotter and his trainee, Melvin Judkins, 1st used the catheter for 
intentional percutaneous transluminal angioplasty. The 1st patient to benefit was Laura Shaw, 
an 82-year-old woman who was admitted to the University of Oregon Hospital with a painful 
left foot. The foot had a nonhealing ulcer and gangrenous toes. All of her physicians had 
recommended amputation, but she had refused. Dr. William Krippaehne, a general surgeon, 
handled the vascular cases. He had a good relationship with Dotter, and because Ms. Shaw 
refused surgery, Krippaehne asked Dotter to see her. Dotter found out that Ms Shaw had 
short segmental stenosis of the superficial femoral artery, an ideal lesion upon which to test 
his percutaneous “dilating” catheters7. The procedure went well and within minutes, the 
patient's foot was warm and hyperemic. Her pain disappeared within a week and the ulcer 
soon healed. 
The first use of a coronary stent is typically attributed to Jacques Puel and Ulrich 
Sigwart when they implanted a stent into a patient in Toulouse, France in 1986. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
The clinical material for this study consisted of 150 cases of Diabetic foot patients 
admitted in the surgical wards of Thanjavur Medical College Hospital, Thanjavur during the 
period September 2016 to September 2017.  
 
The patients were selected based on the following criteria: 
1. PATIENT WITH PROVEN DIABETICS. 
2. DIABETIC PATIENTS WITH LOWER LIMB ULCERS AND 
DISCOLOURATION. 
3. DIABETICS PATIENTS WITH LOWER LIMB PAIN. 
The patients were excluded based on the following criteria: 
1. DIABETIC PATIENT WITH TRAUMATIC ULCERS. 
2. PATIENT WITH NON DIABETIC VASO-OCCLUSIVE DISORDERS. 
3. DIABETIC PATIENTS WITH CONCURRENT HYPERCOAGULABLE 
DISEASES. 
4. DIABETIC PATIENTS WITH HANSENS/FILARIAL DIASEASE ARE 
EXCLUDED. 
5.         DIABETIC PATIENTS WITH ULCERS DUE NON VASCULOPAPHIC CAUSE 
 LIKE UNCONTROLLED DIABETICS, NEUROPATHY. 
6.  DIABETIC PATIENTS WITH WELL SET GANGRENE BEFORE ANY 
 MEDICAL/SURGICAL INTERVENTION. 
 
The following data were collected and recorded.  
 In the proforma, name and age of the patient, sex, occupation complaints and history 
in detail were obtained and recorded. Past history of diabetes, hypertension, tuberculosis and 
ischemic heart disease were enquired into. Smoking and alcohol history were elicited with 
special reference. 
          Our study included 150 patients out of which 120  men and 30 women  
 Patients were examined in detail about the general condition like anemia, jaundice, 
fever, blood pressure and peripheral pulses. 
 
The affected part of the foot and the ulcer was examined in detail for all the features of an 
ulcer.  
            Unhealthy granulation, amount of slough, site of ulcer and line of demarcation were 
noted. 
The various nature of presentations were   
1. Cellulitis 
2. Ulceration 
a) Ischaemic ulcer 
b) Neuropathic ulcer 
c) Neuroischaemic ulcer 
3. Gangrenous toes 
4. Gangrenous foot 
 
Various risk factors were analyzed in detail 
1. Loss of protective sensation 
2. Vibration perception    
3. Deformity or limited joint mobility 
4. Presence of peripheral vascular disease 
5. Past history of any ulceration or deformity 
6. Presence of claudication, discoloration  
 
Other detailed on the distal peripheral pulses, ulcers and its location and 
particularly on which vasculosome the ulcer is present, and cause of the ulcer, pain were 
evaluated. Patient were subjected to various other investigation to rule out non vascular 
causes of diabetic foot. Doppler study and angiographic assessment were done to confirm the 
microangiopathy and macroangiopathy and presence of thrombus hindering the perfusion of 
the limb were studied. 
ANKLE BRACHIAL PRESSURE INDEX  
 This was done for peripheral arterial disease. Ankle blood pressure and brachial 
 
 Blood pressure are measured using a Doppler probe.  
 
  Ankle blood pressure  
ABPI =   
  Brachial blood pressure 
 
The following investigations were carried out for all the patients. 
Urine    :    Albumin, Sugar, Deposit 
Blood    :    Hemoglobin, Total Count, Differential 
         Count, Platelet Count, ESR 
Blood    :    Urea 
.                                                    Fasting blood sugar and  
                                                     Post prandial blood sugar (done 2 hours after meal) 
Serum   :                Creatinine, Sodium, Potassium, Chloride,cholestrol 
ECG and X-ray Chest were taken  
Pus culture and sensitivity :    Swab taken from wound site before starting antibiotics.           
                                                     Organism and the appropriate antibiotic were identified. 
Color Doppler Study :    Arterial study for macro vascular diseases. 
                                                     Loss of  triphasic flow and coversion to monophasic  
                                                     flow was noted in each vessel like dorsalis pedis, 
                                                     anterior tibial, posterior tibial, popliteal and femoral 
                                                     arteries.          
CT-Angiography: Computed tomography angiography (also called CT angiography or 
CTA) is computed tomography technique used to visualize arterial and venous vessels,to look 
for atherosclerotic plaques in the vessels throughout the lower limb. It plays a very important 
role in assessing the vascularity of the limbs while planning for surgeries in abnormal 
vascularity of lowerlimbs.Its role in diabetic foot is to assess the ulcer perfusion vessels and 
its ischemia cause if any and to plan on endovascular and open procedures for improved 
results 
 
 
X-ray of the foot        :    To look for osteomyelitis of the underlying bone .  
                                                      Like resorption of bone, osteolytic lesion ,cavities 
 
Diabetic status of the patients were examined in detail. 
Other factors like change in colour,pallor,cyanosis,signs of ischemia,Buergers postural 
test,capillary refilling time,venous refilling,guttering of veins were evaluated .some other 
palpation findings like crossed leg(fuchsig’s test),cold and warm water test, Allen 
test,Branham’s sign or Nicoladonis sign,hyperabduction manoeurve and if gangrenous area 
present; it was examined in detail . 
Renal parameters of patients were given special significance. 
 
              The mode of treatment given – whether conservative, surgical debridement, 
Revascularization  procedures like open and endovascular procedures or amputation,  
patients clinical improvement, limb perfusions and were recorded in the proforma.  
 
CONSERVATIVE MANAGEMENT: 
-Medical treatment protocols of patients were organized with antiaggregant/anticoagulant, 
statin and vasodilator therapies. Blood glucose range was controlled with crystallized insulin. 
-Diet (low fat, low salt, high fibre ) 
-Exercise 
-Patient education-regarding weight reduction 
-Pharmacological  therapy- Sulphonylurea    
                                             Biguanides 
                                             Insulin-given based on sliding scale 
                
  Blood sugar                                Insulin 
121-150                                           4U 
  151-180                                         6U 
 181-220                                          8U 
 221-250                                         10U   
 251-275                                         12U 
 276-300                                         14U 
-Daily urine sugar chart  
-Thorough wound debridement- EUSOL bath 
-Daily wound dressing    
- Blood transfusion for anemic patients 
 
REVASCULARIZATION PROCEDURES: 
Revascularization was performed for relief of intermittent claudication in 60% of the 
subjects. With the advent of catheter-based interventional therapies for PAD, endovascular 
physicians have become able to improve arterial perfusion in the lower extremity through the 
use of balloon angioplasty and stenting. Low procedural morbidity and high procedural 
success have led to an enormous increase in the use of these therapies in the treatment of 
intermittent claudication. Neither ankle brachial indexes nor duplex ultrasonography was 
used to determine whether the revascularized artery remained patent. Without 
revascularization, patients with critical limb ischemia have a high risk of amputation. 
Vascular and endovascular surgeons are increasing their use of endovascular therapies 
because of the low attendant cardiovascular risk and the perceived reduction in symptoms. 
Remarkably, despite the conviction that these procedures provide benefit to patients. Quality 
of life of patients and ulcer healing time and improvement in perfusion of leg have been 
increased by angiographic procedures. 
                                           BALLOON ANGIOPLASTY AND STENTING 
BALOON CATHETER AND INFLATED, 
VESSEL DILATED AND VASCULARITY 
OF ISCHEMIC AREAS WELL PERFUSED 
ALLOWING DIABETIC PATIENTS FAST 
AND EARLY HEALING AND PREVENTS 
LIMB FROM ISCHEMIA. 
 
 
 
 
 
 
SURGICAL MANAGEMENT: 
Open bypass were done. Peripheral artery bypass is surgery to reroute the blood 
supply around a blocked artery in one of your legs. Fatty deposits can build up inside the 
arteries and block them. 
A graft is used to replace or bypass the blocked part of the artery. The graft may be a 
plastic tube, or it may be a blood vessel (vein) taken from your body (most often the opposite 
leg) during the same surgery. The unique pattern of lower extremity atherosclerosis in 
diabetes is a critical determinant of the revascularization strategy. Most diabetics with critical 
ischemia have popliteal/tibial occlusions requiring below-the-knee intervention or bypass 
grafting. Autologous saphenous vein grafts were used in all patients for distal bypass 
procedures. Inflow anastomoses were performed with 6.0 monofilament suture and outflow 
anastomoses were performed with 6.0 or 7.0 monofilament suture. A 100 U/kg of heparin 
was administered before arterial clamping, and heparin was not reversed after the flow was 
maintained. 
 
Additional risk factors are former amputation and recurrent ulcers, and treatment with insulin 
may increase the risk of amputation despite distal revascularization procedures in diabetic 
patients with critical limb ischemia. 
Details of the level and type of amputation performed was recorded. 
         In our series amputations were done at different anatomical levels ranging from toe  
level to above knee amputation .  
Initially guillotine amputation was done for severely infected, necrotic cases 
Later the patients underwent revision amputation 
-Types of amputations done were a) Toe disarticulation – Ray’s amputation  
                                                       b) Below knee amputation 
                                                       c) Through knee amputation 
                                                       d) Above knee amputation 
Post-operative Rehabilitation; 
After stump wound healing suture removal was done and all postoperative amputee 
were immobilized with stump Plaster of Paris to prevent flexion contractures. 
 
 
 
 
 
 
 
 
 
 
 
MANAGEMENT BASED ON THE MODE OF PRESENTATION: 
Doppler study and ABPI, vascular assessment for all diabetic patients were done 
1. CELLULITIS:  -Parenteral antibiotics 
-Limb elevation 
-Foot care 
2. FOOT ULCER: -Parenteral antibiotics, medical/surgical Revascularization. 
                                 -Wound debridement 
                                 -Daily dressing 
                                 -Reconstructive surgery like skin graft 
3. GANGRENOUS TOES: -Vascular assessment 
- Medical/surgical Revascularization. 
                                              - Disarticulation/ Ray’s amputation 
4. GANGRENOUS FOOT:--Vascular assessment 
-Amputation at appropriate level 
 
 
Patient History And Physical Examination 
Diabetics, lower limb ulcer,Discolouration,Pain 
 
 
Abnormal vascular assesement 
(Doppler, CT-Angiogram) 
 
                                                                                    ABPI* 
 
0.9-1.2 <0.8 >1.2 
Normal vascularity                                    Abnormal vascularity,               Atherosclerotic evaluation 
                                                                       Risk of Limb Ischemia vessel calcification 
 
 
Routine Diabetic and                                   Diabetic control,                         Assess the limb vascularity 
& 
Wound management                                   Antiplatelets                        Need of interventional 
procedures 
 
 
                          Fitness for endovascular/open Revascularization                  DM Control,antiplatelets 
                                                           Procedures 
 
                                   If unfit – continue medical management                  If there is the risk of limb 
ischemia 
                                   Heparin,Cilastazole,wound management                
                                                                                                                                Assess the Patient for  
                                                                                                                           Revascularization 
procedures 
*ABPI is subject of variability with patients diabeties,vessel disease and not considered as primarily 
modality 
In prognosis of patient. 
 
 
STUDY DESIGN 
AND PROTOCOL: 
 
REVIEW OF LITERATURE 
 
 Diabetic foot represents a formidable clinical problem. Successful treatment requires 
a thorough understanding of the pathologic process, surgical debridement of devitalized 
tissue and updating various modalities of treatment. Failure to expeditiously recognize the 
cause, pathology and associated infectious process may lead to devastating consequences, 
like amputation and death.  
Loudon in 1805, had quoted that “Leg ulcers are generally looked upon as an inferior 
branch of practice, an unpleasant and inglorious task where much labor must be bestowed 
and little honour gained8”.  
 
In 1997, the American Diabetes Association proposed the following diagnostic criteria for 
diabetes.  
1. Symptoms and Random plasma glucose > 200mg/dl. 
2. Fasting plasma glucose > 126mg/dl on two occasions.  
3. 75g OGTT 2 hrs plasma glucose >200mg/dl/  
Impaired fasting Glucose (IFG) 
 110 to 125mg/dl 
CLASSIFICATION OF DIABETES: (ADA 1997) 
1. Type 1 diabetes (Immune mediated) 
2. Type 2 diabetes. 
3. Other specific types. 
4. Gestational diabetes mellitus.  
COMPLICATIONS 
1. Acute a) Diabetic ketoacidosis  
  b) Hyper osmolar hyperglycemic, nonketotic syndrome.  
2. Chronic  a) Microvascular disease  
  b) Retinopathy  
  c) Nephropathy 
  d) Macrovascular disease  
  e) Neuropathy.  
 
MANAGEMENT  
Goals:   To achieve a 
1. Fasting blood glucose 80-120mg/dl.  
2. Bed time glucose 100-140mg/dl. 
3. Hemoglobin A1C less than 7%.  
 
MODALITIES OF TREATMENT: 
1. Diet (low fat, low salt, high fibre carbohydrate diet) 
2. Exercise  
3. Patient education 
4. Pharmacological therapy: Sulphonylureas 
Biguanides 
Alpha-glucosidase inhibitors. 
Insulin 
 
 
 
 
 
 PATHOLOGY OF DIABETIC FOOT ULCER 
 
Multifactorial etiology is characteristic.  
Diabetes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Smoking 
Hypertension 
Dyslipidaemia 
Limited 
joint 
Mobility 
NEUROPATHY 
Motor   Sensory  Autonomic 
Damage Damage Damage 
Microcirculatory  
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Foot posture 
Reduced pain and 
proprioception 
A-V 
Shunting 
Increased foot 
pressures Reduced tissue 
nutrition Orthopaedic 
problems charcot 
arthropathy 
Callus 
formation ISCHAEMIA 
ULCERATION 
Infection 
Macrovascular  
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 NEUROPATHY: 
 
Diabetic neuropathy affects the somatic motor, sensory and the autonomic nervous system. 
Sensory neuropathy can lead to extrinsic neuropathic foot ulceration following trauma9. The 
initial trauma is often minor and may be due to ill- fitting footwear, foreign bodies in shoes, 
toenail cutting and thorn pricks. Sensory neuropathy paradoxically produces pain and 
paraesthesias. 
 
 
Hyperglycemia  
  
 
Increased cellular glucose    Competitive inhibition of sodium  
      Dependent myoinositol uptake 
 
Increased Sorbitol     Decreased myoinositol 
 
      Decreased Na/K pump activity  
 
Direct neurotoxicity    Impaired Nerve conduction  
 
 
 
Somatic motor neuropathy results in weakness of the intrinsic muscles of the foot, which 
allows abnormal movement of the small bones of the foot. As a result, joint subluxation 
occurs. Attenuation of the Achilles reflex is an early sign of motor neuropathy. 
 
 Because of sensory neuropathy, the patient continues to walk on the damaged foot and 
the bony structure of the foot is altered permanently10 
 
 These lead to deformities like claw foot, prominent metatarsal heads, Varus 
malformation and rocker – bottom foot. 
Inflammation of these subluxated joints results in charcot’sarthropathy. 
The bony changes produce localized areas of high pressure on the sole with callus formation, 
and eventual ulceration. 
Autonomic neuropathy produces abnormal vasomotor response. Autosympathectomy 
increases arteriovenous shunting which leads to osteopenia and functional ischemia. 
Hypohidrosis results in dry, cracked skin, which increases the susceptibility to ulceration and 
infection.        
 
MICROVASCULAR DISEASE: 
 Due to excessive glycosylation of collagen and glycoproteins, the extra cellular matrix 
is altered. The basement membrane is thickened and there is increased capillary permeability. 
Although there is an absolute over perfusion at rest, there remains a relative hypoperfusion of 
tissues because of tissues increased metabolic rate and lessened ability to vasodilatation in 
response to noxious stimuli. The vasoconstrictor response to the vertical posture is also 
reduced with the result that capillary pressure raises11. This increases oedema formation with 
the effect of impairing tissue perfusion. 
 
 
   HYPERGLYCEMIA  
 
    Increased  Glucose flux  
 
    Increased  Diacyl glycerol 
 
   Increased protein  kinase C activity  
 
 
Permeability    Vasoactive hormones   Basement membrane 
    Blood flow changes   synthesis  
    
 HEMODYNAMIC HYPOTHESIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Macrovascular Disease: 
 
• Diabetics are 4 to 7 times more prone for atherosclerosis. This  
 Process also appears to be accelerated. 
• In diabetics, atherosclerosis tends to affect the femoropopliteal   
 And tibial vessels.  
• The media of arteries in diabetes tends to become calcified which  
 Results in making measurement of ankle brachial indices unreliable  
 
Increased 
coagulability 
Platelet 
Hypersensitivity 
Increased 
microvascular 
Increased blood viscosity Microvascular sclerosis 
Impaired 
microvascular flow 
Limitation of maximum 
perfusion 
Failure 
of 
autoregulation 
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INFECTION: 
• Diabetic foot ulcers are characterized by polymicrobial infection with gram 
 positive and gram negative aerobes and anaerobes. 
• Staphylococcus aureus, Bacteroides. Proteus, Enterococcus, Clostridia and 
 Escherichia coli are commonly present.  
• Infection is usually secondary. 
• Fungal infection between the toes can lead to skin breakdown and secondary 
 ulceration  
• The infection may remain superficial, spreading cellulitis can develop or the 
 infection can spread into the deeper tissues. 
• Arterial insufficiency and the diminished inflammatory response facilitates for 
the rapid progression of any infection. 
 
INSULIN RESISTANCE 
 
ATHEROSCLEROSIS 
CONNECTIVE TISSUE ABNORMALITIES: 
 Advanced glycosylation end products form covalent cross-linking with other proteins 
including collagen and keratin. This cross – linking produces tissues that are rigid, inflexible 
and resistant to proteases. 
 
 The rigidity of the subcutaneous tissues renders it more likely to be torn by shear 
forces. Wound contraction is also affected. 
The collagen of the ligaments and joint capsule become inelastic and weak contributing to 
foot deformities. 
 
HAEMOTOLOGICAL DISTURBANCE: 
 
 Red cells are less deformable possibly due to glycosylation of their cell membrane. 
 There is a tendency towards hypercoagulability12. 
 White cell function is impaired with the resultant decreased resistance to infection. 
 
MEGGITT WAGNER WOUND CLASSIFICATION  
 
I. Superficial wound  
II. Penetrates to tendon or bone  
III. Deep with osteitis 
IV. Partial foot gangrene  
V. Whole foot gangrene. 
 
  
 
DIABETIC FOOT RISK CLASSIFICATION SYSTEM: - 
 
 Category 0 protective sensation intact  
 Category 1  Loss of protective sensation (LOPS) 
 Category 2 LOPS + Deformity  
 Category 3 LOPS + Deformity + H/o previous ulcer or amputation 
  
Category 4 A Noninfected nonischemic wound  
 Category 4B Acute Charcots Arthropathy 
 Category 5  Diabetic foot infection  
 Category 6 Critical ischemia   
 
 
 
 
 
 
 
 
 
 
 
 
 
INVESTIGATIONS: 
For proper management of diabetic foot, the most important thing is a thorough clinical 
examination and a few specific investigations for vasculopathy and neuropathy13. 
 
BASELINE TESTS: 
 Urine analysis  
 Complete blood count  
 Blood sugar – fasting and postprandial: 
To assess the glycemic status and the dosage of insulin required. 
 Blood urea and serum creatinine  
In all diabetics, renal parameters should be evaluated since renal 
failure can coexist with diabetes 
 Serum sodium and Potassium  
Serum electrolytes are evaluated since electrolyte imbalance is 
common in ketotic and non- ketotic hyperglycemia14. 
 
 
 
Palpation of Pulses: 
Palpation of dorsalis pedis and tibial pulses resulting in a strong arterial pulse (0, non-
ischemic), palpable but slightly diminished (1, mild), thready and scarcely. Palpable (2, 
moderate) and non-palpable pulses (3, severe). 
 
 
 
 
SPECIAL TESTS: 
ANKLE BRACHIAL PRESSURE INDEX  
 It is done for peripheral arterial disease. Ankle blood pressure and brachial blood 
pressure are measured using a Doppler probe.  
  Ankle blood pressure  
ABPI =   
  Brachial blood pressure 
 ABI has the advantages of low cost, simplicity, high reproducibility and specificity, 
and therefore is often used as a standard test for screening for PAD. IN the literature, the 
sensitivity of ABI is 95%, and the specificity 99%.14 ABI normal reference value is 1.00 -
1.30, 0.91 to 0.99 for borderline PAD. ABI > 1.30 or higher usually means vascular 
calcification, and impaired arterial elasticity. ABI less than or equal to 0.90 is considered 
abnormal. ABI 0.71 to 0.90 indicates mild PAD, ABI 0.41 to 0.70 as moderate and ≤ 0.40 as 
severe PAD or critical limb ischemia. It is recommended that people with type 1 and type 2 
diabetes should be screened annually for PAD, to ensure early diagnosis and initiate prompt 
treatment, if present. Although ABI is a better way to discover and evaluate PAD, research 
has shown that ABI is not sensitive enough in detecting PAD in the early stage. Additionally, 
calcinosis of the arterial wall in diabetes, can falsely Elevate ABI thus under estimating PAD 
prevalence15.Therefore, interpretation of ABI results should be combined with clinical and 
other examination results. If ABI > 1.30, toe brachial index (TBI) may be measured. In 
addition to ABI and TBI, a lower extremity arterial color Doppler ultrasound examination 
should be carried out in order to further confirm diagnosis of PAD. This is because ABI in 
the lower limb arteries of people with diabetes can be falsely elevated or high (> 1.3) even 
Though blood supply to the limb has been reduced. Therefore, although ABI is the most 
convenient method for diagnosis of PAD in people without diabetes, it needs to be combined 
with TBI and clinical signs & symptoms in diabetic foot wound assessment. 
 
Doppler Ultrasound Examination 
 ABI is the method of detecting blood flow in lower extremity arteries while arterial 
color Doppler ultrasound is the examination of the lower extremity artery morphology. In 
people with diabetes, PAD tends to occur in the small arteries, so without assessing distal 
tothe popliteal artery, PAD detection rate is low. If blood flow assessment is based on color 
Doppler ultrasound instrumentation, coupled with experienced ultrasound operators, the 
accuracy of color Doppler examination of lower extremity arteries results are close to the 
lower limb CT angiography (CTA). The benefit being color Doppler ultrasound is 
noninvasive and costs much less than CTA.More importantly, as mentioned above, if the 
signs and symptoms of lower limb ischemia are present but ABI is not lower than 0.9, this 
results in the emergence of “pseudo hypertension” and enables the ultrasound examination to 
successfully diagnose PAD. Color Doppler ultrasound can show the arterial wall, thickening, 
atherosclerotic plaque and calcification degree, such as lumen stenosis, color flow obvious 
filling defect, or arterial occlusion, which decreases arterial wall elasticity falsely elevating 
the ABI, which results in the diagnosis of PAD. 
 
 
Vascular Imaging: 
 If ABI is in the normal reference and on examination and assessment clinical signs 
and symptoms of PAD are present, further advanced imaging such as CTA or MRA 
(magnetic resonance angiography), or digital subtraction angiography (DSA), is not 
necessary and withoutbenefits.16 It may be necessary, however, to further diagnose PAD and 
assess severity and location of lesion with this advanced imaging to develop appropriate 
treatment programs16. 
 
COMPUTED TOMOGRAPHY ANGIOGRAPHY: 
 Computed tomography angiography (also called CT angiography or CTA) is 
computed tomography technique used to visualize arterial and venous vessels throughout the 
body. This ranges from arteries serving the brain to those of bringing blood to the lungs, 
kidneys, arms and legs. CT angiography of the lower extremities is a important and versatile, 
noninvasive tool for diagnosis as well as surgical open or endovascular interventional 
planning. Although lower extremity CTA is most commonly performed in patients with 
peripheral artery disease or trauma affecting the lower extremities, it also plays a role in the 
workup of non-ischemic etiologies such as vasculitis, aneurysms, and congenital vascular 
malformations. CT scan protocols should adjust bolus timing and multiphasic imaging to 
account for the clinical question of interest, and 3-dimensional post processing plays an 
important role in the visualization and interpretation of these high-resolution imaging 
examinations. 
 It plays a very important role in assessing the vascularity of the limbs while planning 
for surgeries in abnormal vascularity of lowerlimbs.Its role in diabetic foot is to assess the 
ulcer perfusion vessels and its ischemia cause if any and to plan on endovascular and open 
procedures for improved results.CTA is usually advised for patients who have abnormal 
pulses and abnormal vascular Doppler studies. Precise, comprehensive imaging of the arterial 
circulation is the cornerstone of successful revascularization of the ischemic extremity in 
patients with diabetes mellitus. Arterial imaging is challenging in these patients because the 
disease is often multisegmental with a predilection for the distal tibial and peroneal arteries. 
Occlusive lesions and the arterial wall itself are often calcified and patients presenting with 
ischemic complications frequently have underlying renal insufficiency. Intra-arterial digital 
subtraction angiography (DSA), contrast enhanced magnetic resonance angiography (MRA), 
and more recently, computerized tomographic angiography (CTA) have been used as imaging 
modalities in lower extremity ischemia. Each has specific advantages and shortcomings in 
this patient population, which will be summarized and contrasted in this review. 
 DSA is an invasive technique most often performed from a femoral arterial puncture and 
requires the injection of arterial contrast, which can occasionally cause allergic reactions. In 
patients with pre-existing renal insufficiency, contrast infusion can result in worsening renal 
failure; although usually self-limited, it may occasionally require hemodialysis, especially in 
patients with diabetes. However, DSA provides the highest degree of spatial resolution and 
image quality. It is also the only modality in which the diagnosis and treatment of arterial 
disease can be performed simultaneously. MRA is noninvasive, and when enhanced with 
gadolinium contrast injection provides arterial images of comparable quality to DSA and in 
some circumstances may uncover distal arterial targets not visualized on DSA. However, 
spatial resolution is inferior to DSA and erroneous interpretations due to acquisition artifacts 
are common. Specialized equipment and imaging techniques are necessary to minimize their 
occurrence in the distal lower extremity. In addition, due to the risk of inducing nephrogenic 
systemic fibrosis, gadolinium-enhanced MRA cannot be used in patients with renal 
insufficiency. 
 CTA is noninvasive and rapidly performed, with better spatial resolution than MRA, 
but requires the largest volume of contrast infusion, exposes patients to high-doses of 
radiation, and is subject to interpretive error due to reconstruction artifacts especially in 
heavily calcified arteries, limiting its usefulness in many patients with diabetes. For patients 
in whom the planned intervention is a surgical bypass, DSA and MRA will provide high 
quality images of the lower extremity arterial anatomy. For patients in whom a catheter-based 
intervention is the likely treatment, a diagnostic DSA immediately followed by a catheter-
based treatment in the same procedure is the preferred approach. In patients with pre-existing 
renal dysfunction, in which gadolinium-enhanced MRA is contraindicated, DSA or CTA can 
be performed. However, patients should have an infusion of intravenous normal saline 
solution or sodium bicarbonate before the procedure to reduce the incidence of contrast-
induced nephropathy. 
 Precise, comprehensive anatomic imaging is the cornerstone of successful 
revascularization of the ischemic lower extremity in patients with diabetes mellitus. Contrast 
arteriography has been the mainstay for many years and remains the gold standard due to its 
superior image resolution and being the only modality used for both diagnosis and treatment. 
However, magnetic resonance angiography (MRA), and more recently, computerized 
tomographic angiography (CTA), have become viable alternatives due to being inherently 
less invasive with image quality rivaling digital subtraction angiography (DSA). 
  Imaging of arterial anatomy in the lower extremity of patients with diabetes presents 
unique challenges due to the distal location of the occlusive lesions, most commonly 
involving the crural and pedal arteries. Detailed imaging of these vessels is critical in 
planning endovascular procedures or surgical bypass. The presence of multisegment disease, 
the frequency of calcification of both the atherosclerotic lesions and the wall of the arteries 
involved, and the presence of renal insufficiency are additional challenges often encountered. 
Consequently, all three modalities have advantages and disadvantages in specific patients 
based on their clinical presentation and comorbidities17.The use of cut-film radiographs and 
rapid film changers has long given way to intra-arterial DSA, the current standard for contrast 
arteriography of the lower extremity. DSA has especially improved the imaging of diabetic 
arterial occlusive disease due to its superior ability to visualize distal small caliber vessels 
with less contrast. Currently available machines have completely automated sequences that 
set exposure values and frame speed for the various arterial segments studied in the abdomen, 
pelvis, and lower extremity. Improved computer processing power and equipment design has 
made the commonly used techniques such as subtraction, re-masking, pixel shifting and 
stacking, or view tracing fast and simple. Road-mapping and subtracted image referencing 
(fluoro-save mode) used during catheter-directed interventions are easily performed by the 
operator at the table. Gantry angle, table position, collimation, magnification, and edge filters 
are easily changed by the operator to optimize imaging for any arterial segment. 
 
                PICTURE – CT ANGIOGRAM SHOWING OCCLUSION AT ILIAC LEVEL 
 
                 PICTURE – 3D CT ANGIOGRAM showing Anterior Tibial occlusion 
 
 
 
ARTERIAL ANATOMY OF LOWER LIMB: 
In the Thigh and Gluteal Region 
Femoral Artery 
The main artery of the lower limb is the femoral artery. It is a continuation of the 
external iliac artery (terminal branch of the abdominal aorta). The external iliac becomes the 
femoral artery when it crosses under the inguinal ligament and enters the femoral triangle 
In the femoral triangle, the profundafemoris artery arises from the posterolateral aspect 
of the femoral artery. It travels posteriorly and distally, giving off three main branches: 
• Perforating branches – Consists of three or four arteries that perforate the adductor 
Magnus, contributing to the supply of the muscles in the medial and posterior thigh. 
• Lateral femoral circumflex artery – Wraps round the anterior, lateral side of the 
femur, supplying some of the muscles on the lateral aspect of the thigh. 
• Medial femoral circumflex artery – Wraps round the posterior side of the femur, 
supplying its neck and head. In a fracture of the femoral neck this artery can easily be 
damaged, and avascular necrosis of the femur head can occur. 
 
Fig 1.0 – The anatomical course of the femoral artery, and its branches. 
After exiting the femoral triangle, the femoral artery continues down the anterior 
surface of the thigh, via a tunnel known as the adductor canal. During its descent the artery 
supplies the anterior thigh muscles. 
The adductor canal ends at an opening in the adductor Magnus, called the adductor 
hiatus. The femoral artery moves through this opening, and enters the posterior compartment 
of the thigh, proximal to the knee.  The femoral artery now known as the popliteal artery. 
 
 
Other Arteries of the Thigh 
 Fig 1.1 – Arterial supply to the posterior thigh and gluteal region. 
In addition to the femoral artery, there are other vessels supplying the lower limb. 
The obturator artery arises from the internal iliac artery in the pelvic region.  It descends 
via the obturator canal to enter the medial thigh, bifurcating into two branches: 
• Anterior branch – This supplies the pectineus, obturator externus, adductor muscles 
and gracilis. 
• Posterior branch – This supplies some of the deep gluteal muscles. 
The gluteal region is largely supplied by the superior and inferior gluteal arteries. These 
arteries also arise from the internal iliac artery, entering the gluteal region via the greater 
sciatic foramen. 
The superior gluteal artery leaves the foramen above the piriformis muscle, the inferior 
below the muscle. In addition to the gluteal muscles, the inferior gluteal artery also 
contributes towards the vasculature of the posterior thigh. 
In the Leg 
The popliteal artery descends down the posterior thigh, giving off genicular branches 
that supply the knee joint. It moves through the popliteal fossa, exiting sandwiched between 
the gastrocnemius and popliteus muscles. At the lower border of the popliteus, the popliteal 
artery terminates by dividing into the anterior and posterior tibial arteries. 
The posterior tibial artery continues inferiorly, along the surface of the deep muscles 
(such as tibialis posterior). It accompanies the tibial nerve in entering the sole of the foot via 
thetarsal tunnel. During the descent of the posterior tibial artery in the leg, the fibular 
artery arises. This artery moves laterally, penetrating the lateral compartment of the leg. It 
supplies muscles in the lateral compartment, and adjacent muscles in the posterior 
compartment. 
The other division of the popliteal artery, the anterior tibial artery, passes anteriorly 
between the tibia and fibula, through a gap in the interosseous membrane. It then moves 
inferiorly down the leg. It runs down the entire length of the leg, and into the foot, where it 
becomes the dorsalis pedis artery. 
 Fig 1.2 – Arterial supply to the posterior leg, via the popliteal artery and branches 
 
Fig 1.3 – Arterial supply to the anterior leg, via the anterior tibial artery. 
In the Foot 
Arterial supply to the foot is delivered via two arteries: 
• Dorsalis pedis (a continuation of the anterior tibial artery) 
• Posterior tibial 
The dorsalis pedis artery begins as the anterior tibial artery enters the foot. It passes over 
the dorsal aspect of the tarsal bones, then moves inferiorly, towards the sole of the foot. It 
then anastamoses with the lateral plantar artery to form the deep plantar arch. The dorsalis 
pedis artery supplies the tarsal bones and the dorsal aspect of the metatarsals. Via the deep 
plantar arch, it also contributes to the supply of the toes. 
The posterior tibial artery enters the sole of the foot through the tarsal tunnel. It then 
splits into the lateral and medial plantar arteries. These arteries supply the plantar side of the 
foot, and contributes to the supply of the toes via the deep plantar arch18 
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ANGIOGRATHIC ASSESSMENT AND MANAGEMENT OF DIABETIC FOOT: 
PATHOPHYSIOLOGY 
 The pathophysiology of PAD in the diabetic population is similar to that in the non-
diabetic population. However, the distribution of peripheral atherosclerosis in patients with 
PAD and diabetes is often more distal than in patients without diabetes, and commonly 
involves the tibial vessels. The abnormal metabolic state that accompanies diabetes directly 
contributes to the development of atherosclerosis;proatherogenic changes include increases in 
vascular inflammation and alterations in multiple cell types. Inflammation is an established 
risk factor for the development of atherosclerosis19. Elevated levels of C-reactive protein 
(CRP) are strongly associated with the development of PAD. Furthermore, CRP levels are 
abnormally elevated in patients with impaired glucose tolerance. In addition to being a 
marker of atherosclerosis, elevated levels of CRP may also be a risk factor for PAD. C-
reactive protein has procoagulant effects related to its ability to enhance expression of tissue 
factor. C-reactive protein also inhibits endothelial cell nitric oxide (NO) synthase, resulting in 
abnormal regulation of vascular tone, and increases production of plasminogen activator 
inhibitor-1, which inhibits the formation of fibrinolytic plasmin from plasminogen. Most 
patients with diabetes and PAD demonstrate generalized endothelial cell dysfunction. In 
healthy vessels,endothelial cells synthesize NO, a potent vasodilator that inhibits platelet 
activation and vascular smooth muscle cell migration. Diabetes impairs NO-mediated 
vasodilatation. A number of mechanisms contribute to the decreased bioavailability of 
endothelium-derived NO in diabetes, including hyperglycemia, excess free fatty acids, and 
insulin resistance. The effects of endothelial cell dysfunction increase arterial susceptibility to 
atherosclerosis. 
 In addition to reducing NO concentrations, diabetes increases the production of 
vasoconstrictors, such asendothelin-1, which increase vascular tone and vascular smooth 
muscle cell growth and migration. Diabetes also stimulates other atherogenic pathways in 
vascular smooth muscle cells. For example, hyperglycemia activates protein kinase C and 
nuclear factor kappa-B, increasing the production of reactive oxygen species that promote the 
formation of atherosclerotic lesions. Vascular smooth muscle cells cultured from patients 
with diabetes demonstrate enhanced migration, an important step in the progression to 
advanced plaque formation. These cells strengthen the atheroma, making it less likely to 
rupture and cause thrombosis. However, Fukumoto et al. demonstrated that advanced plaques 
in diabetic individuals have fewer smooth muscle cells than healthy controls; it is believed 
that hyperglycemia-induced lipid modifications regulate the apoptosis of vascular smooth 
muscle cells in advanced atherosclerotic lesions, promoting plaque instability and 
precipitation of clinical events.Platelet aggregation is enhanced in diabetes20. Elevated 
glucose levels activate protein kinase C, decrease production of platelet-derived NO, and 
increase oxidative stress. In diabetes, platelets also have increased expression of glycoprotein 
and IIb/IIIa receptors, enhancing their thrombotic potential.In addition to potentiating platelet 
aggregation, diabetes augments blood coagulability by increasing the expression of tissue 
factor and decreasing levels of anticoagulants, such as antithrombin III21. Consequently, it is 
more likely that atherosclerotic plaque rupture will result in thrombus formation. Thus, 
alterations in metabolism in diabetes adversely affect multiple cell types within the vascular 
wall. The increased tendency towards coagulation, coupled with impaired fibrinolysis, 
contributes to the enhanced thrombotic potential characteristic of diabetes22. 
 
 DIAGNOSIS : 
 The main reasons to diagnose PAD in diabetic individuals are to initiate therapies that 
decrease the risk of atherothrombotic events, improve quality of life, and decrease disability. 
A diagnosis of PAD indicates the presence of systemic atherosclerosis that confers additional 
cardiovascular risk to the patient with diabetes, and gives further impetus to aggressively 
manage vascular risk factors in this high-risk group23. A typical protocol for the diagnosis of 
PAD is shown in methods. A thorough medical history and physical examination are of 
primary importance in evaluating a diabetic individual for the presence of PAD. Information 
about the onset and duration of symptoms, pain characteristics, and any alleviating factors is 
helpful. The clinical stage of symptomatic PAD can be classified using the Fontaine staging 
system. Fontaine stage I represents those who have PAD but are asymptomatic; stages IIa and 
IIb include patients with mild and moderate-to-severe intermittent claudication, respectively; 
those with ischemic rest pain are classified in Fontaine stage III; and patients with distal 
ulceration and gangrene represent Fontaine stage IV24. A typical history of claudication has a 
low sensitivity, but a high specificity for PAD . Physical examination should include blood 
pressure measurement, palpation of peripheral pulses, and auscultation of pulses and bruits. 
Palpation of peripheral pulses should include an assessment of the femoral, popliteal, and 
pedal vessels; pulses should be graded as absent, diminished, or normal25. Dorsalis pedis 
pulse abnormalities are less sensitive for PAD, since up to 30% of these abnormalities may be 
due to a congenital absence of the dorsalis pedis artery. The absence of both the dorsalis 
pedis pulse and the posterior tibial pulse strongly suggests the presence of PAD, but further 
diagnostic testing is required to confirm the diagnosis26. 
 
 
 Fontaine classification27, 28 
Grade Symptoms 
Stage I Asymptomatic, incomplete blood vessel obstruction 
Stage II Mild claudication pain in limb 
Stage IIA Claudication at a distance  >  200 m 
Stage IIB Claudication at a distance  <  200 m 
Stage III Rest pain, mostly in the feet 
Stage IV Necrosis and/or gangrene of the limb 
 
MANAGEMENT: 
1) PHARMACOLOGICAL REVASCULARIZATION MEDICAL MANAGEMENT 
2) OPEN OR ENDOVASCULAR SURGICAL REVASCULARIZATION PROCEDURES 
 
 
 
 
 
 
 
 
 
 
 
 MEDICAL MANAGEMENT 
 When told that walking is not doing harm, many claudicants are Content to live 
within the limitations imposed by their condition. Spontaneous improvement occurs in many 
patients over the first6 months after an occlusive episode as collateral vessels develop. 
Lifestyle advice should be offered. Exercise is encouraged, particularly walking within the 
limits of the disability; supervised exercise programmes are ideal. Stopping smoking is 
essential. Dietary advice is required for those who are overweight and for those with high 
blood lipids. Care of the ischemic foot is often required, especially in diabetics. Medication 
may be required for diseases associated with arterial disorders, such as hypertension and 
diabetes; some antihypertensive(particularly β-blockers) may exacerbate claudication. Raised 
blood lipids require active drug treatment but even when the lipid profile is normal a statin 
should be prescribed (e.g.40 mg/day of pravastatin). An antiplatelet agent is also necessary, 
usually 75 mg day−1 of aspirin, with 75 mg day−1 of clopidogrel as an alternative for those 
who are aspirin intolerant. Other agents, such as vasodilators, are unlikely to prove 
beneficial.Anticoagulants (or sometimes known as “blood thinners”) are medicines that delay 
the clotting of blood29. Examples are heparin, warfarin, dabigitran, apixaban, and 
rivoraxaban. Anticoagulants make it harder for clots to form or keep existing clots from 
growing in your heart, veins or arteries. 
 
 
 
 
 
 
 
 
 
Pharmacotherapy for Patients with PVD 
DRUGS DOSAGE COMMENTS 
DRUGS DOSAGE COMMENTS 
Aspirin 81 to 325 mg 
per day orally 
Recommended by the surgeons for PAD 
Clopidogrel 
(Plavix) 
75 mg per day 
orally 
Fewer side effects than aspirin in the CAPRIE trial; 
significantly less risk for TTP than ticlopidine 
Pentoxifylline 
(Trental) 
1.2 g per day 
orally 
May have a small effect on walking ability, but 
insufficient data to support widespread use 
Cilostazol 
(Pletal) 
100 mg twice 
per day orally 
Correct dosing is critical; avoid in patients with 
heart failure; reduce dosing to 50 mg twice per day 
in patients taking calcium channel blockers; may 
cause loose stools and gastric upset 
Ticlopidine 
(Ticlid) 
 
500 mg per 
day orally 
Extensive hemodynamic monitoring for risk of TTP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aspirin 
Aspirin is a platelet aggregator inhibitor/anti-inflammatory. Therapeutic actions of 
aspirin are the Prevention of blood clot formation (specifically in coronary arteries), decrease 
of inflammation, pain control, and decrease of fever. Prevention of platelet clumping and 
blood clot formation by Irreversible changes in platelet shape and function. The analgesic, 
anti-inflammatory, and antipyretic 2-4 hours. Aspirin represents the first-line of antiplatelet 
drugs. Low-dose aspirin (75-325 mg) is as effective as higher doses30. However, higher doses 
of aspirin result in increased risk of gastrointestinal (GI) bleeding and very low-doses (<75 
mg) are less effective. Clopidogrel is used in place of low-dose aspirin in patients who have 
aspirin-related intolerance or allergy. Combined antiplatelet therapy is slightly more effective 
than aspirin alone only in patients with a history of established vascular disease. Oral 
anticoagulant therapy alone or in combination with aspirin was in PAD patients not shown to 
be more effective than aspirin alone in prevention of cardiovascular events, but is probably 
more effective in prevention of graft occlusion. However the combination is related to an 
increased risk of bleeding. Moderate intensity of warfarin treatment would be acceptable in 
the presence of coexisting indications such as atrial fibrillation or recent venous thrombosis. 
Cilostazol 
Cilostazol is a phosphodiesterase type 3 inhibitor to treat intermittent claudication. Its 
possible mechanism of action includes increasing intracellular concentrations of cAMP, 
thereby causing vasodilation and inhibiting platelet aggregation. Although other drugs with 
vasodilating and platelet-inhibiting properties have not been demonstrated to improve 
claudication symptoms, cilostazol is effective in ameliorating symptoms. Of note, cilostazol 
decreased triglyceride concentration by 16% and increased high-density lipoprotein levels by 
13%, but also increased the incidence of headache, bowel concerns, and palpitations. 
Cilostazol may have an additional benefit of reducing restenosis and repeat 
revascularization following endovascular therapy. Similar to patients with coronary artery 
disease, patients with PAD have lower rates of target vessel revascularization following 
cilostazol therapy31. However, these studies have been small and open label in design, thus 
hypothesis generating. 
 
 
Pentoxifylline 
Pentoxifylline is a xanthine derivative used to treat patients with intermittent 
claudication. Its mechanism of action is thought to be a rheological modifier that includes 
improving the deformability of red blood cells and white blood cells, and decreasing 
fibrinogen concentration, platelet adhesiveness, and whole-blood viscosity. A meta-analysis 
demonstrated a modestly improved walking distance, substantially less effective than either 
cilostazol or a supervised exercise program. 
Medical Treatment of the Patient Undergoing Revascularization 
Antiplatelet therapy has good evidence for the prevention of graft occlusion after 
peripheral vascular surgical procedures. Aspirin with or without other antiplatelet therapy 
was associated with a significantly lower risk of graft occlusion.Ticlopidine has also been 
shown to promote vein graft patency without any difference in cardiovascular events. Dual-
antiplatelet therapy with aspirin plus clopidogrel versus aspirin alone was tested in the 
clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease 
(CASPAR) trial32.There was no significant difference in the primary end point (graft 
occlusion, amputation, or death) between groups. In a subgroup analysis, clopidogrel plus 
aspirin was better than aspirin alone among patients who received prosthetic grafts. As 
expected, bleeding was more common in the dual-antiplatelet therapy group. 
Anticoagulation has also been recommended as an adjuvant to maintain surgical graft 
patency. The use of heparin anticoagulation in the immediate postoperative period, 
particularly low-molecular-weight heparin, may improve the patency of infrainguinal bypass 
grafts (vein and prosthetic), but has also been associated with increased bleeding. The role of 
long-term oral anticoagulation is more controversial. In one trial of patients undergoing 
infrainguinal bypass surgery (including the use of vein, prosthetic material, and 
endarterectomy), long-term warfarin was associated with an increased bleeding risk but no 
benefit in patency or survival. In contrast, another study performed in a similar population 
demonstrated that oral anticoagulation improved graft patency, limb salvage, and survival. 
Several trials have compared the benefits of anticoagulation versus antiplatelet 
therapy. Among patients treated with infrainguinal bypass procedures (predominantly using 
prosthetic material), randomization to low-molecular-weight heparin versus aspirin and 
dipyridamole was associated with better graft patency, especially in the patients treated for 
critical limb ischemia. Half the patients were treated for claudication and the other half were 
treated for critical limb ischemia with a fairly even distribution of vein versus prosthetic 
material. The aspirin dose was 80 mg/d, and, in patients randomly assigned to 
anticoagulation, the international normalized ratio was maintained at 3.0 to 4.5. The primary 
end point of patency was equal between groups after 21 months follow-up. In contrast, 
aspirin maintained prosthetic graft patency better than anticoagulation. Although these results 
suggest that patients receiving vein grafts should be preferentially treated with warfarin and 
those with prosthetic material with aspirin, adequately powered studies are needed to 
determine the optimal antithrombotic and antiplatelet strategy following vascular surgery. 
In the context of promoting patency after a revascularization procedure, antiplatelet 
and antithrombotic therapy have a clear. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
OPEN OR ENDOVASCULAR SURGICAL REVASCULARIZATION PROCEDURES 
Endo-vascular management: This is similar to all the intervention described for 
managing coronary arteries of the heart. A balloon catheter is used to dilate blood vessels and 
a stent is used to keep it open. Gruntzig and Dotter C T were the first to design these 
catheters. Last five years witnessed phenomenal advances in endovascular surgeries. Now 
even long synthetic grafts can be kept using endovascular techniques. Angioplasty is a 
procedure to open narrowed or blocked blood vessels that supply blood to your legs. Fatty 
deposits can build up inside the arteries and block blood flow. A stent is a small, metal mesh 
tube that keeps the artery open. Angioplasty and stent placement are two ways to open 
blocked peripheral arteries. Angioplasty uses a medical "balloon" to widen blocked arteries. 
The balloon presses against the inside wall of the artery to open the space and improve blood 
flow. A metal stent is often placed across the artery wall to keep the artery from narrowing 
again. 
 
1.  ENDOVASCULAR STRATEGIES FOR MANAGEMENT OF CLAUDICATION 
AND LOWER EXTREMITY ATHEROSCLEROTIC DISEASES: 
In 1964, Dotter and Judkins introduced therapeutic percutaneous angioplasty of 
atherosclerotic peripheral plaques, a technique used multiple coaxial catheters of various 
sizes to dilate the stenosis. In the mid-1970s, Andreas Gruentzig, at the University of Zurich, 
Switzerland, developed a double lumen balloon catheter-used to dilate lesions in the iliac and 
femoral arteries safely and with a high rate of procedural success. Devices and the technique 
for extremity arterial disease are balloon angioplasty, rotational atherectomy, stents, rheolytic 
thrombectomy and distal embolic protection devices. 
Percutaneous transluminal angioplasty for claudication: 
The major determinants for separating patients between surgical disease and percutaneous 
transluminal angioplasty (PTA), aside from surgical candidacy, are expected short- and long 
term patency results. Noncalcified, more focal nonostial stenoses are the most favorably 
treated by balloon dilatation. This would also presume the absence of other indications for 
surgical approach such as associated aneurismal disease. The percutaneous approach to 
infrainguinal arterial disease is much like that of the aortoiliac region, but with diminished 
longevity like it surgical counterpart. Similar to the surgical tenant of trying to stay above the 
knee in the therapy for intermittent claudication, the percutaneous approach is primarily 
guided towards short stenosis of the superficial femoral and popliteal arteries above the knee 
with an infra-geniculate approach primarily reserved for patients with debilitating 
claudication and/ or symptoms at rest. 
                                    The American Heart Association  Committee again classified lesion 
that are most favorable for angioplasty to be single nonostial stenosis less than 3cm in the 
length that are not heavily calcified and above the knee. Lesions approaching 10cm in length 
(including occlusions) with runoff disease of increasing severity are more appropriate for 
surgical therapy. The major complication are all in the order of 2-5% and include puncture 
site hematomas and/or subsequent pseudoaneurysms, intimal dissection (which may, 
depending upon its severity, be a normal sequela of balloon dilatation rather than a 
complication ), arterial rupture ,and distal embolization. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Directional atherectomy: 
Although it was initially hoped that directional atherectomy would demonstrate a lower 
degree of restenosis as has been suggested in some coronary interventional data, long-term 
follow-up results of femoral or popliteal directional atherectomy has demonstrated 
disappointing results. Directional atherectomy is reserved for therapy of lesions resistant to 
balloon dilatation at safe inflation pressures, for treatment of either eccentric lesion or 
complications of angioplasty such as dissection. Complication of angioplasty are generally 
related to the catheter size and location of the puncture site, severity of the patient’s disease 
and associated co-morbid  conditions such as hypertension or a need for anticoagulation or 
thrombolysis. 
Intravascular stents: 
The first bare metal stents approved for peripheral arterial use is the Palamaz balloon –
expandable intra-luminal stent (Johnson and Johnson International Systems, Warren NJ). The 
use of this stent has been effective in reducing residual gradient across lesions following iliac 
angioplasty that may have been caused by either recoil of the vascular wall or flow limiting 
intimal dissection. Long-term studies indicate that iliac artery stenting provides better long -
term patency than the angioplasty alone in prospective randomized trials. Metallic stenting 
has significantly less restenosis rate compared to balloon angioplasty for lower extremity 
arteries. Whereas early PTA failures in infra-femoral sites can often be salvaged by the use of 
a bare metallic stent, the long term results have been plagued by intimal hyperplasia and stent 
occlusion. Although no large prospective, methodologically impeccable randomized study is 
available, it appeared until recently that short-term patencies are similar to those of PTA 
alone. The introduction of drug-eluting stents, Sirolimus-Eluting, may solve the problem of 
instant restenosis in LEAD. Drug-eluting stents are a very promising advance. They could be 
the answer for lesions, and the presence of diabetes mellitus. Drug-eluting stents have not 
been adequately and long term evaluated in LEAD or vein graft lesions. Bio-degradable 
stents are the products of another technological advancement. A potential advantage of bio-
degradable stents is that they leave a large potential surgical target. 
 
 
 
Thrombolysis: 
Selective arterial thrombolysis is usually utilized in the setting of acute limb jeopardy. 
However, acute or subacute onset of claudication can be treated with thrombolytic therapy. In 
addition, chronic occlusions, particularly in the iliac artery, can sometimes be better 
recanalized with the adjunctive use of thrombolytic therapy allowing the placement of a 
balloon catheter and subsequent intravascular stent.  
                                For claudication resulting from either thrombotic or embolic occlusions, 
Urokinase has been extensively utilized over past two-and-a half decades. The choice of 
Urokinase over other thrombolytic agent, stems from studies asserting its higher efficacy to 
complication rates when used in the peripheral arterial system. In general, thrombotic 
occlusions respond much better than the emboli to regional thrombolysis. The therapy is 
rarely effective if a guidewire cannot transverse the occlusion, and the results are most 
efficacious when a multiside holed catheter can be placed to infuse the agent directly into 
thrombus. In the case of chronic occlusion (especially in the iliac region) an infusion of 
Urokinase may allow recanalization of a channel through which further intervention can be 
performed. There are three absolute contraindications to the initiation of thrombolytic 
therapy: (1) active uncontrollable hemorrhage, (2) likely persistent proximal source of 
embolization, or (3) neurovascular compromise in the affected extremity, where it is likely 
that a reperfusion injury such as myonecrosis may develop. Relative contraindication include 
recent intra-abdominal or intrathoracic surgery, uncontrollable hypertension, a recent 
intracerebral event that is likely to be hemorrhagic, and possibly the recent use of a porous 
intra-arterial graft material. Thrombolytic complications are proportional to the duration of 
therapy and usually consist of hemorrhage, often related to concomitant need for 
anticoagulation. 
 
 
 
 
 
 
Subintimal angioplasty: 
In 1990, Bolia and colleagues first reported the technique of subintimal angioplasty. 
Unintentional dissection of the arterial wall occurs not uncommonly and is usually without 
sequelae, but until recently was considered an indication to abandon further attempts at 
angioplasty. Bolia observed that successful outcome could be achieved if the accidentally 
created subintimal false lumen was pursued, with re-entry in to the true lumen beyond the 
distal extent of the occlusion. Thus, the concept of deliberate subintimal angioplasty was 
born. Importantly, technical failure does not preclude conventional revascularization surgery, 
and complications of this technique may often be corrected with standard endovascular 
procedures. Subintimal angioplasty is a technically difficult procedure with a long learning 
curve. Results are inferior to surgical bypass, and this technique is not widely performed in 
the United States. Nonetheless, it does represent yet another option for limb salvage in the 
management of select patients with severe lower extremity occlusive disease.    
 
 
 
                            PICTURES OF ENDOVASCULAR ARTERIAL STENTING 
 
 
SURGICAL PROCEDURE: 
     The indications for limb revascularization are: 
1) Disabling claudication and ulcer 
2) Critical limb Ischemia-rest pain or necrosis 
          Surgical revascularization procedures in diabetic patients are tolerated extremely well 
with excellent outcomes and morbidity and mortality rates equals to those of nondiabetic 
patients and no greater than those of major amputation patients and no greater than those of 
major amputation. IN flow (aortoiliac/femoral) procedures and outflow 
(femoral,popliteal,tibial/peroneal,and pedal) procedures can be tailored to an individual 
diabetics patient’s needs depending on the location and extent of disease and what the bypass 
in being asked to do ,associated risk factors, and the patient’s overall wellbeing. Age is no 
contraindication to revascularization. 
Lack of a target vessel, unavailability of autogenous vein,or irreversible gangrene 
beyond the midfoot may preclude revascularization. In such patients a choice must be made 
between prolonged medical therapy and primary amputation. 
Bypass to the tibial or pedal vessels with autogenous vein has a long track record in 
limb salvage and remains the most predictable method of improving blood flow to the 
threatened limb. The procedure is safe, durable and effective. Three fourth of infrainguinal 
procedures in patients with diabetes are below the knee by pass, with the exterior 
tibial/dorsalis pedis artery the most common target vessel. Indeed, surgical bypass with 
greater saphenous vein has become the procedure of choice for patients with diabetes and 
tibial disease34. 
Intermittent claudication per se is not an indication for surgical intervention. 
Structured exercise programmes develop good collaterals in the majority. Revascularization 
procedures are indicated in ‘Critical ischemia’ as a limb salvage procedure or in acute setting 
when embolism is suspected. 
The common site of blocks in blood vessels are in aorta and femoral artery. Inserting 
grafts between aorta and iliac arteries and femoral and popliteal arteries are done using 
reversed long saphenous vein or by synthetic PTFE and Dacron grafts.Aorto-iliac or Aorto-
femoral grafting is the treatment of choice in good risk patients, with good distal runoff. The 
approach is distal runoff. The approach is usually trans peritoneal. Decron prosthesis gives a 
very good (95%)five year patency. 
Calculation may pose technical difficulty of cross clamping. Distal outflow may be 
improved by judicious endarterectomy. Femoral popliteal bypass is very useful 
revascularization surgery. For below knee anastomosis saphenous vein is the conduit of 
choice. Distal bypasses or more often required in diabetics and usually the dorsalis pedis may 
be used as a good outflow vessel. Sequential grafting may be necessary in situations where 
angiography reveals an isolated popliteal artery (Blind popliteal artery syndrome). Outflow 
anastomosis may be require venous cuffs to reduce neo intimal proliferation. Embolectomy: 
Acute limb ischaemia is managed by embolectomy using balloon catheters (Fogarty’s 
catheter). The catheter with a balloon in the tip is inserted through an arteriotomy and intra-
arterial intra operative thrombolytic therapy can also be done. Remembering that diabetics 
have a predilection for tibial and peroneal arteries occlusive disease, restoration of pulsatile 
blood flow to achieve the most rapid and durable healing of extensive tissue loss, gangrene, 
or incisions from local forefoot procedures. Reperfusion of the foot makes ulcers heal and 
reduces pain in the foot. An ischaemic foot is so endangered that minimal sepsis is enough to 
produce infective gangrene. In diabetes when the foot is insensate the patient is oblivious of 
symptoms of ischaemia and delays surgical treatment. The surgical importance of the 
profundafemories artery was discussed by Morris et al and Leeds et al in the early 1960s. The 
revascularization of the deep femoral artery to treat peripheral arterial occlusive disease was 
introduced by Natali in 1962. Cotton and Roberts popularized the deep extended 
profundaplasty in the 1960s. martin and Bouhoutsosfavored a patch over a short length. 
Profundaplasty35 is still a valuable option for patients with femoral PAD and claudication 
without tissue loss. It is straightforward procedure that combines good efficacy with low 
complication rates. Further endovascular treatment may be facilitated. Profundaplasty can be 
used in selected patients suffering from claudication or critical ischemia. Diabetes is a 
systemic disease and hence management of ischemia foot involves attention to correction of 
systemic multiple organ dysfunction. Lifestyle modification as in coronary artery disease, 
like attention to lipids,cessation of smoking and control of systemic hypertension is an 
essential step. Cigarette smoking is the single most important modifiable risk factor for the 
development and exacerbation of PAD. In patients with PAD, tobacco use is associated with 
increased progression of atherosclerosis as well as increased risk of amputation. Thus, 
tobacco cessation counselling and avoidance of all tobacco products is absolutely essential. 
Hyperglycemia is a cardiovascular risk factor in diabetics. Good glycaemia control 
(A1C<7.0%) should be a goal of therapy in all patients with PAD and diabetics in order to 
prevent microvascular complications. Critical ischaemia has been shown to be associated 
with 62% of cases in which there has been non healing ulceration and a causal factor of 46% 
of amputations33. The morbidity and mortality of vascular surgical procedure in patients with 
diabetes has improved significantly and the outcomes are now comparable with those of non-
diabetics. Diabetes mellitus does not influence late mortality, graft patency, or limb salvage 
rates after lower extremity arterial reconstruction. Bypass grafting to the infrageniculate and 
inframalleolar vessels is routinely performed in patients with diabetes mellitus who are 
undergoing revascularization for limb salvage. The dorsalis pedis artery in the foot has been 
touted as possibly being the best target vessel to use in the patients with diabetes mellitus 
because of its relative sparing from atherosclerosis. Aggressive use of lower extremity bypass 
grafting, including foot level bypass has been advocated as the best approach to limb 
threatening ischaemia and non healing ulcers, and excellent results routinely reported in the 
recent years support this view.      
 
                      PICTURE-OPEN BYPASS FOR FEMPOP OCCLUSION DONE IN 
TMCH 
 
Saphenous vein graft for  
fempop bypass 
  
 
 
 
 
OBSERVATION 
 
 
Various factors were observed and analyzed. 
The statistics were made using the Software Graph Pad Prism Version 5. 
ABPI is subject of variability with patients diabetes vessel disease and not considered as 
primarily modality in outcome of patient 
 
 
 
 
 
 
 
Table 1: Age distribution of the study subjects involved in the study (overall) 
 
S. 
No Age (in years) Number (n) Frequency (%) 
1  ≤35 12 8 
2 36-45 31 20.67 
3 46-55 54 36 
4 56-65 34 22.66 
5 66 - 75 18 12 
6 >75 1 0.67 
 
 
Data are expressed as absolute numbers with percentage. 
 
Figure 1: Age distribution of the study subjects involved in the study (overall) 
 
 
 
Table2: Statistical description of age of the study subjects. (overall) 
 
S. 
No parameter Value 
1 Mean 52.4 years 
2 Median 52 years 
3 Mode 50 years 
4 Standard deviation 10.6 
5 Variance 112.5 
6 Range 30 to 87 years 
 
 
 
 
 
 
 
  
Table 3: Comparison of age in years between the groups in the study population 
 
 
 
S. 
No Age in years 
Normal group  
(n=42) 
PVD with 
revascularization 
done 
(n=52) 
PVD with only 
antiplatelet drugs given 
(n=56) 
1 Mean years 48.31 52.79  55.13 
2 Standard deviation 9.5 11.6  9.59 
3 Median years 47 52.5  55 
Statistical values of the comparison between the groups. Test used: ANOVA 
S.No Group 
comparison Mean difference P value 
95% confidence 
interval 
1 
Normal group Vs 
PVD with 
revascularization 
-4.47 0.052 (NS) -9.54 to 0.58 
2 
Normal group Vs 
PVD with only 
antiplatelet drug 
-6.815 0.0006* -11.8 to -1.83 
3 
PVD with 
Revascularization 
VS PVD with 
only antiplatelet 
group 
-2.337 0.255 (NS) -7.04 to 2.367 
 
The sample sizes are unequal in all three groups. * indicates p <0.05 and is considered 
statistically significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2: Comparison of age in years between the groups 
 
 
Data are expressed as mean with standard deviation. The height of the bar in the vertical bar 
diagram represents the mean and the error bars represents the mean. N in normal group is 42, 
PVD treated with RV was 52 and PVD treated with antiplatelet drugs was 56. ANOVA with 
Bonferroni multiple comparison was used to test the statistical differences between the 
groups. * indicates p<0.05 and considered statistically significant. PVD= Peripheral vascular 
disease; RV = Revascularization & APD = Antiplatelet drugs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: Distribution of gender in the study population. 
 
S. 
No Type of the group 
Gender 
Male Female 
N % N % 
1 Overall (n=150) 119 79.3 31 20.7 
2 Normal group (n=42) 29 69.04 13 30.96 
3 PVD with revascularization done (n=52) 47 90.38 5 9.62 
4 
PVD with treated with 
antiplatelet drugs only 
(n=56) 
43 76.78 13 23.21 
Figure 3: Distribution of gender proportions in the study in various groups 
 
 
 
 
 
 
Table 5: Frequency distribution of type of artery involved in the PVD with 
revascularization done as treatment group (n=52) 
 
S. 
No Type of the artery involved Number (n) Frequency (%) 
1 Anterior tibial artery 12 23.08 
2 Posterior tibial artery 18 34.62 
3 Anterior and posterior tibial artery 3 5.77 
4 Femoral artery 4 7.69 
5 Bilateral femoral artery 1 1.92 
6 Popliteal artery 7 13.46 
7 Femoral with popliteal artery 4 7.69 
8 Iliac artery 3 5.77 
 
Figure 4: Frequency distribution of artery involved in the PVD with revascularization done as 
treatment group (n=52) in pie chart. 
 
 
 
Data are expressed as percentage. The area in the pie chart represents the percentage value of 
each group. 
 
 
Table 6: Frequency distribution of type of artery involved in the PVD treated 
with antiplatelet drugs group (n=56) 
 
S. 
No Type of the artery involved Number (n) Frequency (%) 
1 Anterior tibial artery 6 10.71 
2 Posterior tibial artery 6 10.71 
3 Dorsalis pedis artery 38 67.86 
4 Popliteal artery 5 8.93 
5 Iliac artery 1 1.79 
 
 
 
 
 
 
Figure 5: Frequency distribution of artery involved in the PVD treated with anti 
platelet drugs only group (n=56) in pie chart. 
 
 
Data are expressed as percentage. The area in the pie chart represents the percentage value of 
each group. 
 
 
 
Table 7: Comparison of frequency of anti-platelet drug received in various        
groups 
 S. 
No Type of the group 
Antiplatelet drugs received 
Yes No 
N % N % 
1 Overall (n=150) 111 74 39 26 
2 Normal group (n=42) 3 71.4 39 28.6 
3 PVD with revascularization done (n=52) 52 0 0 0 
4 
PVD with treated with 
antiplatelet drugs only 
(n=56) 
56 0 0 0 
 
 
Table 8: Outcome of wound healing in the normal group of the study population 
(n=42). 
 
S. 
No Quality of the wound healing Number (n) Frequency (%) 
1 None 2 4.8 
2 Poor 3 7.1 
3 Better 18 42.9 
4 Good 15 35.7 
5 Excellent 4 9.5 
 
 
Table 9: Outcome of wound healing in the PVD treated with revascularization 
group of the study population (n=52). 
 
S. 
No Quality of the wound healing Number (n) Frequency (%) 
1 None 10 19.2 
2 Poor 4 7.7 
3 Better 2 3.8 
4 Good 4 7.7 
5 Excellent 32 61.5 
 
 
Table 10: Outcome of wound healing in the PVD treated only with the 
antiplatelet drugs group in the study population (n=56). 
 
S. 
No Quality of the wound healing Number (n) Frequency (%) 
1 None 2 3.6 
2 Poor 6 10.7 
3 Better 14 25 
4 Good 19 33.9 
5 Excellent 15 26.8 
 
 
 
 
Figure 6: Description of different qualities of wound healing in various groups in the study 
 
 
 
Table 11a: Comparison of excellent quality of wound healing between the groups 
 
S. 
No 
Quality of 
wound healing Group comparison 
Proportions Statistical test 
And p value PVD 
with RV  
PVD with 
APD  
1 Excellent  
PVD with RV  
Vs 
PVD with APD 
32/52 15/56 
Fisher’s exact test 
(p=0.0004*) 
Relative risk = 2.2 
(95% CI =1.14 to 3.7) 
 
 
 
 
 
Table 11b: Comparison of excellent quality of wound healing between the groups 
 
S. 
No 
Quality of 
wound healing Group comparison 
Proportions Statistical test 
And p value Normal PVD with RV 
1 Excellent  Normal Vs PVD 
with RV 4/42 32/52 
Fisher’s exact test 
(p<0.0001*) 
Relative risk = 6.4 
(95% CI =2.4 to 16.8) 
 
 
Table 11c: Comparison of excellent quality of wound healing between the groups 
 
S. 
No 
Quality of 
wound healing Group comparison 
Proportions Statistical test 
And p value Normal  PVD with APD 
1 Excellent  Normal Vs PVD 
with APD 4/42 15/56 
Fisher’s exact test 
(p=0.04*) 
Relative risk = 2.8 
(95% CI =1.07 to 7.8) 
 
On comparison of wound healing within Various groups Normal Vs PVD with 
Revascularization Vs PVD with Antiplatelet, the proportions for PVD With RV Vs PVD with 
APD were 32/52 for RV and 15/56 for APD, using the Fischer’s exact test theP Value is 
0.0004 which is statistically significant and the Relative Risk is 2.2 which is under positive 
Range which shows that patients are definitively benefitted by this study who underwent 
various Revascularization and Antiplatelet Drugs (Table 11a). , 
 
 
 The proportions for PVD with RV Vs Normal group were 32/52 and 4/42, using the 
Fischer’s exact test the P Value is < 0.0001 which is statistically significant with Relative 
Risk of 6.4(Table 11b). , The proportions for Normal Vs PVD with APD were 4/42 and 
15/56, using the Fischer’s exact test the P Value is 0.04 which is statistically significant 
with Relative Risk of 2.8 (Table 11c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
Diabetic foot ulcer is the commonest cause of foot ulcers in Thanjavur Medical College 
Hospital, Thanjavur. In this study, the incidence of Diabetic foot ulcers increased with age, 
which correlates with the literature. 
        The total number of patients included in my study were 150. 
120 were male patients accounting for 80% of the total 
30 were female patients accounting for 20% of the total 
Incidence of diabetic foot increased with advancing age in our study. Incidence of 
diabetic foot was more in age group more than 52years. Out of 150 patients 108 patients 
belonged to this age group. 
On comparison of age groups among the groups of study population, who were 
medically managed with antiplatelet and with those managed using surgical 
revascularization procedures. The mean age of normal group are 48 years and those who 
were treated with antiplatelet only were 55years and those treated with revascularization 
were 52 years, and these  were comparatively analyzed using ANOVA test which showed 
mean difference for normal group vs Peripheral vascular disease(PVD) with 
revascularization was -4.47 and normal group vs PVD with only antiplatelet are -6.815 and 
p value is 0.0006,as the value is <0.05 which indicates the sample size and comparison is 
statically significant(Table 3). 
On studying the gender distribution in study population, out of overall 150 numbers, 
the normal group had 42 numbers, out of which 29 were male and 13 were female.in 
population of those treated with revascularization in patients with PVD, totally 52 patients 
were benefitted which includes 47 males and 5 females. Of those 56 patients who were 
treated with antiplatelet only 43 were male and 13 were female (figure 3). 
On studying the distribution of type of artery involved in the PVD with 
revascularization done on study groups ( n=52), involvement of Anterior tibial artery is 12 
with frequency(%) of 23.08, Posterior tibial artery is 18 with frequency(%) of 
34.62,Anterior tibial artery and posterior is 3 with frequency(%) of 5.77,Femoral artery is 4 
with frequency(%) of 7.69,bilateral femoral artery is 1 with frequency(%) of 1.92,Popliteal 
artery is 7 with frequency(%) of 13.46,Fempop artery is 4 with frequency(%) of 7.69,Iliac 
artery involvement is 3 and frequency is 5.77(Table 5). 
On studying the distribution of type of artery involved in the PVD with antiplatelet 
drugs done on study groups ( n=56), involvement of Anterior tibial artery is 6 with 
frequency(%) of 10.71, Posterior tibial artery is 6 with frequency(%) of 10.71,Dorsalis 
pedis artery is 18 with frequency(%) of 67.86, Popliteal artery is 5 with frequency(%) of 
8.93,Iliac artery involvement  is 1 and frequency is 1.79(Table 6).this shows the distal 
collateral arteries are mostly managed using the antiplatelet drugs rather than going for 
endovascular procedures. Of various outcomes studies, the major relief for the patient was 
relieved from claudication and improvement from ischemic changes and wound healing. 
Out of which wound healing was intensively followed for better significance, which 
eventually proves patients were improved from pain and symptoms of ischemia. The scale 
made were EXCELLENT (if wound healing was <4 weeks duration), GOOD (if wound 
healing was 4 to 6 weeks duration), BETTER (if wound healing was 6 to 12 weeks 
duration) and finally POOR (If > 12 weeks duration or patients went for failures of 
intervention or major amputation performed, which does not include pre study period 
factors gangrene or uncontrolled diabetics, osteomyelitis, chronic infections who needed 
lifesaving amputations)  
                         Diabetic foot with PVD ,both ATA and PTA involvement  
 
Revascularization Tibial stenting with antiplatelets done and gangrenous toes                                                    
disarticulated,patient got positive ATA and PTA 
 
 
Digital subtraction Angiogram and Tibial STENTING done under C-ARM guidance. 
  
The outcomes of wound healing in the PVD treated with Revascularization group of 
study Population (n=52), the excellent wound healing is seen in 32 patients with frequency of 
61.5 % And good in 4 patients and better in 2 patients and poor in 4.In those of patients with 
PVD treated with Antiplatelets alone (n=56) , Excellent wound healing was seen in 15 
patients with frequency of 26.8% And Good in 19, better in 14 patients and poor in 6 patients. 
On comparison of wound healing within Various groups Normal Vs PVD with 
Revascularization Vs PVD with Antiplatelet, the proportions for PVD With RV Vs PVD with 
APD were 32/52 for RV and 15/56 for APD, using the Fischer’s exact test the P Value is 
0.0004 which is statistically significant and the Relative Risk is 2.2 which is under positive 
Range which shows that patients are definitively benefitted by this study who underwent 
various Revascularization and Antiplatelets Drugs (Table 11a). , the proportions for PVD 
with RV Vs Normal  group were 32/52 and 4/42, using the Fischer’s exact test the P Value 
is< 0.0001 which is statistically  significant with Relative Risk of 6.4(Table 11b).  
 The proportions for Normal Vs PVD with APD were 4/42 and 15/56, using the Fischer’s 
exact test the P Value is 0.04 which is statistically significant with Relative Risk of 2.8 
(Table 11c). 
 
The overall Results shows that the patients who had 
ANGIOGRAPHIC ASSESEMENT AND MANAGEMENT IN DIABETIC FOOT 
PATIENTS HAD GOOD WOUND HEALING, RELIEVED OF ISCHEMIA AND 
LESS AMPUTATION RATES. 
   
 
CONCLUSION 
 
-Ischemia of the lower limb is an important social health problem. Limb salvage in 
patients with extensive tibial and peroneal occlusive disease is feasible with aggressive 
revascularization of the vessels of the ankle and foot.  
-The main goal of distal arterial revascularization procedures is to eliminate 
symptoms, achieve recovery of ulcers, obtain high graft patency and return the patients to an 
active social life. 
-In patients with Diabetic foot, Angiography like Doppler and CT angiography play a 
major role in assessing the arterial status and disease and plan its intervention.  
-Distal arterial Revascularization in patients with critical limb ischemia is a limb 
saving procedure. This study had proven that early assessment of arterial disease and 
treatment with medical and surgical Revascularization procedure has salvaged many limbs of 
the patients and improved the wound healing and symptoms of ischemia. 
- This study had shown incidence of Arterial involvement and success rate of 
revascularization procedure and Antiplatelet in those patients with peripheral vascular 
disease. Lower limb ischemia is a serious event in patients with diabetes mellitus. 
- The consequences may include increased mortality and morbidity in this particular 
patient population. However, distal arterial revascularizations are considerably effective 
procedures to avoid amputation, to eliminate symptoms, to promote ulcer recovery and to 
help the patient participate in social life. 
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 ABBREVIATIONS 
 
 
 
 
A  : Absent 
AK  : Above knee 
AMP  : Amputation 
AntrTib : Anterior Tibial Artery 
ABPI               :           ankle brachial pressure index 
APD                :           antiplatelet drugs 
BK  : Below Knee 
BL   : Bilateral 
CTA                :           Computed tomography angiography 
DSA                :           digital subtraction angiogram 
DP   : Dorsalis Pedis Artery 
Fem   : Femoral Artery 
Lt   : Left 
LOPS              :           Loss of protective sensation 
MRA               :           magnetic resonance angiography 
NPC   : Neuropathic Change 
Nrml  : Normal 
NO                  :           nitric oxide 
P   : present 
Pop  : Popliteal artery 
PstrTib : Posterior  Tibial Artery 
PVD   : Peripheral Vascular Disease 
Rt  : Right 
RV                  :           Revascularization 
 
 
 
 
 
 
 
 
 
  
 
 DEPARTMENT OF GENERAL SURGERY 
THANJAVUR MEDICAL COLLEGE 
THANJAVUR 
 
PROFORMA 
 
Name:     Age/Sex  IP No:  
Date of admission: 
Date of Surgery: 
Date of discharge: 
Address:        Phone No: 
  
PRESENTING COMPLAINTS: 
 Pain    Yes/No  Site: ......................................................... 
Weakness   Yes/No  Site: ......................................................... 
Hot/cold  Yes/No  Site: ......................................................... 
Numb/sensitive  Yes/No  Site: 
......................................................... 
Discolouration Yes/No  Site: ......................................................... 
Gangrene  Yes/No ` Site: ......................................................... 
Pigmentation  Yes/No  Site: ......................................................... 
Swelling  Yes/No  Site: ......................................................... 
Ulceration  Yes/No  Site: ......................................................... 
Mass abdomen  Yes/No  
 
PAIN: 
Type:   Vascular claudication: Yes/No  
  Venous claudication:  Yes/No  
  Neurogenic claudication: Yes/No  
Onset:   Gradual / Sudden 
Duration:   ........................days 
Course:   Static/Better /Worse /Fluctuates 
Rest pain:   Yes/No  
Interferes with:  Sleep/ Work/ Exercise 
Influencing factors: (A-Aggravates,R-Relieves,O-No effect) 
 Elevation :   .................. 
 Dependency:  .................. 
 Exercise:   .................. 
 Rest:    .................. 
 Heat:    .................. 
Cold:    .................. 
Weather change:  .................. 
Vibrations:   .................. 
Others:  .......................................................................................... 
Other arterial territories: 
 Fainting:    Yes/No  
 Blackouts/blurred vision:  Yes/No  
 Chest pain:    Yes/No  
 Abdominal Angina:   Yes/No  
 Weakness/paresthesia of UL’s:  Yes/No  
Impotence:     Yes/No 
PAST HISTORY 
MEDICAL HISTORY 
Peripheral Nerves: Sensory/motor loss 
Diabetes Mellitus:  Yes/No 
    Duration ............................................................ 
    OHA:  Yes/No 
    Insulin: Yes/No 
    Controlled/uncontrolled 
Hypertension:   Yes/No 
Collagen vascular disease:  Yes/no 
FAMILY HISTORY 
NIDDM/IDDM:  Yes/No 
CVA/TIA:   Yes/No 
Cardiac disease:   Angina/CCF/MI/Arrhythmia/DOE 
Clotting abnormality:  Yes/No 
PERSONAL HISTORY 
Tobacco:   Bidi/cigarette/Hooka/Gutka 
Alcohol:   Yes/No 
      
PHYSICAL EXAMINATION 
Pulse:    .................. 
BP:   
ABPI:   RLL   .................. 
   LLL   .................. 
EXTREMITIES: 
Skin:   RUL  LUL  RLL  LLL 
Warm/cool  .................. .................. .................. .................. 
Atrophic /thickened .................. .................. .................. .................. 
Cyanosis (Y/N)  .................. .................. .................. .................. 
Mottling (Y/N)  .................. .................. .................. .................. 
Pallor (Y/N)  .................. .................. .................. .................. 
Erythema (Y/N)  .................. .................. .................. .................. 
Ulcerated (Y/N)  .................. .................. .................. .................. 
Pigmentation (Y/N) .................. .................. .................. .................. 
Liposclerosis (Y/N) .................. .................. .................. .................. 
Hair growth (N/dec) .................. .................. .................. ..................  
Nails(Normal/brittle) .................. .................. .................. .................. 
Cellulitis (Y/N)  .................. .................. .................. .................. 
Lymphangitis (Y/N) .................. .................. .................. .................. 
Edema (Brawny/pitting) .................. .................. .................. .................. 
Buerger’s postural test: Positive / Negative;  Angle: .................. 
Capillary filling time: .................. 
Venous refilling:   Yes / No; Angle: .................. 
Gangrene: 
 Yes / No:   .................. 
Extent:   .................. 
 Dry / Wet:   .................. 
 Line of demarcation:  Yes / No: 
 Skip lesions:   Yes / No 
 Limb above gangrenous area: ......................................................... ....................... 
PALPATION: 
Skin temperature: Normal/ decreased/ warm 
Capillary filling:      Normal/Delayed/Absent 
Venous refilling:      Present/absent 
Fuchsig’s test:       Positive / Negative 
Cold & warm water test:     Positive / Negative 
Elevated arms test:      Positive / Negative 
Allens test:     Positive / Negative; Rt/Lt; Radial / Ulnar 
Costoclavicular compression test:    Positive / Negative 
Hyperabduction test:      Positive / Negative 
Muscle mass: Normal / Hypertrophy /Atrophy; Site:........................................... 
Joint swelling: Yes/No; Site:.............................................................................................. 
Reflexes: Normal/Increased/Decreased; Site:......................................................... 
Sensory system: Normal/Increased/Decreased; Site:................................................ 
Motor system: Normal/Increased/Decreased; Site:.................................................... 
Deformity/fracture: Yes/No; Site:............................................................................... 
ARTERIAL PERIPHERAL  PULSE  SURVEY: 
Site:    RIGHT     LEFT 
 Pulse   Pulse     
Femoral  
Popliteal 
DPA   
PTA  
ATA  
Perforators   
INVESTIGATION : 
Hb,TLC,Platelets,FBS,PPBS,Sr. Creatinine,Cholesterol, 
CXR: 
ECG: 
ECHO: EF:..........   RWMA:...................... 
RADIOLOGICAL INVESTIGATIONS: 
Doppler(Arterial) 
Side: 
Site: 
Nature: Stenosis/Occlusion 
...............%block 
ARTERIOGRAPHY: CTANGIOGRAM/MRA/DSA 
 
SURGERY DETAILS: 
 
MEDICAL TREATMENT : 
 
CLINICALLY IMPROVED: 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
  
 
 
 
